Helse Møre og Romsdal HF, Kristiansund sjukehus, Medisinsk Avdeling
Kristiansund, Norway
Location status: Recruiting
NCT Number: NCT04898452
The purpose of the study is to develop and evaluate a new model for across services interaction with the use of welfare technology and telemedicine. The model includes innovative and new routines for the exchange of patient information, quality systems and procedures between the municipality and the hospital. This model will first be tested for use in intravenous antibiotic therapy. The results of the study will be used to further develop the service. In the larger context, it is desirable to provide knowledge that is transferable to other diagnostic groups, treatment methods and geographical areas.
Interested in participating?
Request Info18 year and older
All sexes
Observational
Kristiansund, Norway
Location status: Recruiting
This research-based innovation study has an evaluation approach with follow-up evaluation as the overall approach.
The pre-project was carried out with a qualitative approach under the auspices of SINTEF 2018/2019.
The main project consists of sub-study 1 and sub-study 2 (2020/2022).
Sub-study 1: The project use an iterative, user-centered service methodology with a qualitative approach. Here, SINTEF has the main responsibility for a qualitative summary after conducting interviews, observations and group discussions with patients, next of kins and health professionals regarding the development and testing / quality assurance of the new concept / service course for home treatment.
Sub-study 2: The approach here is quantitative. Descriptive data must be obtained from the hospital and municipal patient records, patient administration system (PAS) at Kristiansund hospital, alarm data from the Regional Response Center and pump log from the individual patient's infusion pump after home treatment.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
A692 Borreliosis G00 - G009 Central nervous system inflammatory disorders I33 Endocarditis J86 Empyema D46.3 Spondylodiscitis M86 Osteomyelitis T84 Prosthesis / osteosynthesis infections M00.0-M00.9 Pyogen / septic arthritis J40-J47 Chronic diseases of the lower respiratory tract
Exclusion criteria
Instead of admitted to the hospital, patients are followed up at home by the municipal regional response center and nurses in the response team according to the individual treatment plan. Hospital physicians are medically responsible throughout the course.
Time frame: 45 months
Time frame: 45 months
assessed with semi-structured interview
Time frame: 45 months
based on answers in web-case-registration-form (CRF)
Contact information is provided by the study sponsor or research team.
Ann Iren Kjønnøy, MSc
CONTACT
Inger Stokke, MSc
CONTACT
Helse Møre og Romsdal HF
Other Gov
Intravenous Antibiotic Treatment at Home: A New Model for Across Services Interaction With the Use of Welfare Technology and Telemedicine.
Acronym: Hosp@Home
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05189925
Chronic Disease, Chronic Granulomatous Disease
Bethesda, Maryland, United States
View Trial DetailsNCT07720856
Infection, Infections
The Bronx, New York, United States
View Trial DetailsNCT06974162
Aqueous Humor, Eye Diseases
London, United Kingdom
View Trial DetailsNCT04821154
Arthritis, Arthroplasty Complications
Fayetteville, Arkansas, United States
View Trial Details